Mark Heffernan is the founder of Scout Bio. Scout Bio has raised $20M in total funding. Latest round: Series A. Based in Philadelphia, United States.
Mark Heffernan founded Scout Bio, a Philadelphia-based biotechnology company focused on developing therapeutics for chronic pet health conditions. He served as CEO of Scout Bio prior to its acquisition by Ceva Santé Animale in January 2024. Following the acquisition, he became the Senior Vice President of Biotherapeutics and Chief Executive Officer of Ceva Biotechnology Campus (Philadelphia) at Ceva Santé Animale.
Full founder directory · Investor directory · Company funding database · Fundraising library